logo
India to maintain Russian oil imports despite Trump threats, government sources say

India to maintain Russian oil imports despite Trump threats, government sources say

Reuters5 days ago
NEW DELHI, Aug 2 (Reuters) - India will keep purchasing oil from Russia despite U.S. President Donald Trump's threats of penalties, two Indian government sources told Reuters on Saturday, not wishing to be identified due to the sensitivity of the matter.
On top of a new 25% tariff on India's exports to the U.S., Trump indicated in a Truth Social post last month that India would face additional penalties for purchases of Russian arms and oil. On Friday, Trump told reporters he had heard that India would no longer be buying oil from Russia.
But the sources said there would be no immediate changes.
"These are long-term oil contracts," one of the sources said. "It is not so simple to just stop buying overnight."
Justifying India's oil purchases from Russia, a second source said India's imports of Russian grades had helped avoid a global surge in oil prices, which have remained subdued despite Western curbs on the Russian oil sector.
Unlike Iranian and Venezuelan oil, Russian crude is not subject to direct sanctions, and India is buying it below the current price cap fixed by the European Union, the source said.
The New York Times also quoted two unnamed senior Indian officials on Saturday as saying there had been no change in Indian government policy.
Indian government authorities did not respond to Reuters' request for official comment on its oil purchasing intentions.
However, during a regular press briefing on Friday, foreign ministry spokesperson Randhir Jaiswal said India has a "steady and time-tested partnership" with Russia.
"On our energy sourcing requirements ... we look at what is there available in the markets, what is there on offer, and also what is the prevailing global situation or circumstances," he said.
The White House did not immediately respond to requests for comment.
Trump, who has made ending Russia's war in Ukraine a priority of his administration since returning to office this year, has expressed growing impatience with Russian President Vladimir Putin in recent weeks.
He has threatened 100% tariffs on U.S. imports from countries that buy Russian oil unless Moscow reaches a major peace deal with Ukraine.
Russia is the leading supplier to India, the world's third-largest oil importer and consumer, accounting for about 35% of its overall supplies.
India imported about 1.75 million barrels per day of Russian oil from January to June this year, up 1% from a year ago, according to data provided to Reuters by sources.
But while the Indian government may not be deterred by Trump's threats, sources told Reuters this week that Indian state refiners stopped buying Russian oil after July discounts narrowed to their lowest since 2022 - when sanctions were first imposed on Moscow - due to lower Russian exports and steady demand.
Indian Oil Corp (IOC.NS), opens new tab, Hindustan Petroleum Corp (HPCL.NS), opens new tab, Bharat Petroleum Corp (BPCL.NS), opens new tab and Mangalore Refinery Petrochemical Ltd (MRPL.NS), opens new tab have not sought Russian crude in the past week or so, four sources told Reuters.
Nayara Energy - a refinery majority-owned by Russian entities, including oil major Rosneft (ROSN.MM), opens new tab, and major buyer of Russian oil - was recently sanctioned by the EU.
Nayara's chief executive resigned following the sanctions, and three vessels laden with oil products from Nayara Energy have yet to discharge their cargoes, hindered by the new EU sanctions, Reuters reported last week.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CureVac settles patent dispute litigation with Pfizer and BioNTech
CureVac settles patent dispute litigation with Pfizer and BioNTech

Reuters

time13 minutes ago

  • Reuters

CureVac settles patent dispute litigation with Pfizer and BioNTech

Aug 7 (Reuters) - CureVac ( opens new tab said on Thursday that the company and GSK (GSK.L), opens new tab have entered an agreement to a resolve patent dispute with Pfizer (PFE.N), opens new tab and BioNTech ( opens new tab related to mRNA-based COVID-19 vaccines. As part of the settlement, CureVac and GSK will receive a combined payment of $740 million and single-digit royalties on sales of COVID-19 vaccines in the U.S. going forward. CureVac will also grant BioNTech and Pfizer a non-exclusive license to manufacture, use, import and sell mRNA-based COVID-19 and influenza products in the U.S.

Judge dismisses US consumer watchdog lawsuit against Experian
Judge dismisses US consumer watchdog lawsuit against Experian

Reuters

time13 minutes ago

  • Reuters

Judge dismisses US consumer watchdog lawsuit against Experian

Aug 7 (Reuters) - A lawsuit filed by the Consumer Financial Protection Bureau against credit rating giant Experian (EXPN.L), opens new tab over credit report accuracy was dismissed on Wednesday, according to a court filing. The lawsuit, filed by the agency in January under the Biden administration, alleged that Ireland-based Experian had failed American consumers who had challenged the accuracy of their reports. Judge Michelle Williams of the Central District of California federal court dismissed the lawsuit without prejudice, allowing the CFPB to file an amended complaint if it wished to do so. The lawsuit was one of the few that had not been abandoned by the Trump administration, which has rolled back the activities of the agency by reducing its workforce by about 90%. The agency dismissed more than 22 cases that were pending against companies such as JPMorgan Chase (JPM.N), opens new tab, Wells Fargo (WFC.N), opens new tab, Bank of America (BAC.N), opens new tab and Capital One (COF.N), opens new tab. The CFPB and Experian did not respond to requests for comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store